Gissou Azabdaftari
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 4
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 5
-
- Prostate Cancer Treatment and Research 17
- Prostate Cancer Diagnosis and Treatment 5
- Renal cell carcinoma treatment 4
- Oncology top 10%
-
- Bladder and Urothelial Cancer Treatments 7
-
- Hormonal and reproductive studies 4
-
- Immunotherapy and Immune Responses 4
- Co-authors
- James L. MohlerKristopher AttwoodBarbara A. FosterLoukia Georgiou KaracostaArthur EdelmanРоберто ПилиJian FengZhixing Hu
- Partner nations
- United StatesArgentinaEgypt
In The Last Decade
Gissou Azabdaftari
44 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 101
- Cancer Research 294
- Molecular Biology 778
- Pulmonary and Respiratory Medicine 363
- Cellular and Molecular Neuroscience 165
- Oncology 244
Countries citing papers authored by Gissou Azabdaftari
This map shows the geographic impact of Gissou Azabdaftari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gissou Azabdaftari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gissou Azabdaftari more than expected).
Fields of papers citing papers by Gissou Azabdaftari
This network shows the impact of papers produced by Gissou Azabdaftari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gissou Azabdaftari. The network helps show where Gissou Azabdaftari may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gissou Azabdaftari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2021 | 2 | |
| 3 | 2020 | 46 | |
| 4 | 2019 | 21 | |
| 5 | 2019 | 74 | |
| 6 | 2019 | 12 | |
| 7 | 2016 | 7 | |
| 8 | 2016 | 152 | |
| 9 | 2015 | 46 | |
| 10 | 2015 | 108 | |
| 11 | 2015 | 3 | |
| 12 | 2014 | 14 | |
| 13 | 2014 | 22 | |
| 14 | 2013 | 29 | |
| 15 | 2012 | 115 | |
| 16 | 2012 | 205 | |
| 17 | 2012 | 3 | |
| 18 | 2012 | 56 | |
| 19 | 2011 | 39 | |
| 20 | 2008 | 86 |
About Gissou Azabdaftari
Gissou Azabdaftari is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Urology, having authored 45 papers that have together received 1.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (17 papers), Bladder and Urothelial Cancer Treatments (7 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Epigenetics and DNA Methylation (5 papers), Renal cell carcinoma treatment (4 papers), Hormonal and reproductive studies (4 papers), Immunotherapy and Immune Responses (4 papers) and Cancer, Lipids, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (294 citations), Molecular Biology (778 citations) and Pulmonary and Respiratory Medicine (363 citations). Gissou Azabdaftari has collaborated with scholars based in United States, Argentina and Egypt. Frequent co-authors include James L. Mohler, Kristopher Attwood, Barbara A. Foster, Loukia Georgiou Karacosta, Arthur Edelman, Роберто Пили, Jian Feng, Zhixing Hu, Zhen Yan and Yong Ren. Their work appears in journals such as The Prostate, The Journal of Urology, Nature Communications, Journal of Biological Chemistry and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.